RFK Jr., who's nominated to become the next health secretary, asked the federal government to revoke its authorization of all ...

In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...

Moderna MRNA provided an update on its financial outlook and pipeline progress at the J.P. Morgan Healthcare Conference. At ...

Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna ...

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to ...

On Jan. 4, 2020, we published the first of what would become a torrent of articles on the disease now known as Covid-19 ...

Investors should be aware of 2025 headwinds, including declining COVID-19 vaccine sales and potential ... the management reiterated their revenue guidance for the 2024 fiscal year to be in the ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...

Earlier this month, GoodRx released a list of the 19 most influential drug and vaccine approvals of 2024, some newly designed to treat certain conditions and other existing medications that were ...